Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)
Report Code: KNJ826832 No. of Pages: 48 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
According to 99Strategy, the Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Tumor Necrosis Factor (TNF) Inhibitor Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
UCB S.A.
Novartis International AG
Pfizer, Inc.
Merck & co., Inc.
Key Product Type
Humira
Enbrel
Remicade
Simponi/Simponi Aria
Cimzia
Biosimilars
Market by Application
Rheumatoid Arthritis
Psoriasis
Psoriatic Arthritis
Crohn’s Disease
Ulcerative Colitis
Ankylosing Spondylitis
Juvenile Idiopathic Arthritis
Hidradenitis Suppurativa
Others
Main Aspects covered in the Report
Overview of the Tumor Necrosis Factor (TNF) Inhibitor Drugs market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development Table of Content
1 Industrial Chain Overview
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry
1.1.1 Overview
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Picture List
1.1.2 Characteristics of Tumor Necrosis Factor (TNF) Inhibitor Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Humira
1.3.2 Enbrel
1.3.3 Remicade
1.3.4 Simponi/Simponi Aria
1.3.5 Cimzia
1.3.6 Biosimilars
1.4 End-Use List
1.4.1 Demand in Rheumatoid Arthritis
1.4.2 Demand in Psoriasis
1.4.3 Demand in Psoriatic Arthritis
1.4.4 Demand in Crohn’s Disease
1.4.5 Demand in Ulcerative Colitis
1.4.6 Demand in Ankylosing Spondylitis
1.4.7 Demand in Juvenile Idiopathic Arthritis
1.4.8 Demand in Hidradenitis Suppurativa
1.4.9 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 AbbVie Inc. Overview
Table AbbVie Inc. Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of AbbVie Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Amgen Inc. Overview
Table Amgen Inc. Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of Amgen Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Johnson & Johnson Services, Inc. Overview
Table Johnson & Johnson Services, Inc. Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of Johnson & Johnson Services, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 UCB S.A. Overview
Table UCB S.A. Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of UCB S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Novartis International AG Overview
Table Novartis International AG Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of Novartis International AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Pfizer, Inc. Overview
Table Pfizer, Inc. Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of Pfizer, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Merck & co., Inc. Overview
Table Merck & co., Inc. Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Operation of Merck & co., Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Humira
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Humira, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Humira, 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Enbrel
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Enbrel, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Enbrel, 2017-2021, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Remicade
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Remicade, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Remicade, 2017-2021, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Simponi/Simponi Aria
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Simponi/Simponi Aria, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Simponi/Simponi Aria, 2017-2021, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Cimzia
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Cimzia, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Cimzia, 2017-2021, in Volume
5.2.5.2 Situation & Development
5.2.6 Market in Biosimilars
5.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Biosimilars, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Biosimilars, 2017-2021, in Volume
5.2.6.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Rheumatoid Arthritis
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Rheumatoid Arthritis, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Rheumatoid Arthritis, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Psoriasis
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Psoriasis, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Psoriasis, 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Psoriatic Arthritis
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Psoriatic Arthritis, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Psoriatic Arthritis, 2017-2021, in Volume
6.2.3.2 Situation & Development
6.2.4 Market in Crohn’s Disease
6.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Crohn’s Disease, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Crohn’s Disease, 2017-2021, in Volume
6.2.4.2 Situation & Development
6.2.5 Market in Ulcerative Colitis
6.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Ulcerative Colitis, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Ulcerative Colitis, 2017-2021, in Volume
6.2.5.2 Situation & Development
6.2.6 Market in Ankylosing Spondylitis
6.2.6.1 Market Size
Figure Global Market Amount and Growth Rate in Ankylosing Spondylitis, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Ankylosing Spondylitis, 2017-2021, in Volume
6.2.6.2 Situation & Development
6.2.7 Market in Juvenile Idiopathic Arthritis
6.2.7.1 Market Size
Figure Global Market Amount and Growth Rate in Juvenile Idiopathic Arthritis, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Juvenile Idiopathic Arthritis, 2017-2021, in Volume
6.2.7.2 Situation & Development
6.2.8 Market in Hidradenitis Suppurativa
6.2.8.1 Market Size
Figure Global Market Amount and Growth Rate in Hidradenitis Suppurativa, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Hidradenitis Suppurativa, 2017-2021, in Volume
6.2.8.2 Situation & Development
6.2.9 Market in Others
6.2.9.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume
6.2.9.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com